Does Independence Blue Cross cover GLP-1s?

What Independence Blue Cross (IBX) says on its own pages (ibx.com), sorted by topic. Your own plan documents decide what you get.

Read Sep 28, 2026. Each line names the plan type it applies to.

Does it cover GLP-1s for weight loss?

IBX says that effective Jan. 1, 2025 it no longer covers GLP-1 or non-GLP-1 drugs indicated for and prescribed solely for weight loss when there is no other FDA-approved clinical indication.Employer and commercial plans:Effective January 1, 2025, Independence Blue Cross (IBX) will no longer offer coverage for drugs —including glucagon-like peptide-1 receptor antagonist (GLP-1) and non-glucagon-like peptide-1 receptor antagonist (non-GLP-1) — indicated for and prescribed solely for weight loss in the absence of other FDA-approved clinical indications.provcomm.ibx.com, Sep 30, 2026
IBX says this Jan. 1, 2025 weight-loss drug exclusion is part of standard benefits for its fully insured group and individual Commercial members.Employer and commercial plans:This change is part of standard benefits for our fully insured group and individual Commercial members.provcomm.ibx.com, Sep 30, 2026
IBX links its May 2025 end of Zepbound OSA coverage to its update excluding coverage of weight loss drugs.Employer and commercial plans:This coverage change aligns with IBX's recent update to exclude coverage of weight loss drugs.provcomm.ibx.com, Sep 30, 2026

IBX says members who have a weight loss benefit through their employer still have coverage for GLP-1 medications, including Zepbound.Employer and commercial plans:Members who have a weight loss benefit through their employer still have coverage for GLP-1 medications, including Zepbound.provcomm.ibx.com, Sep 30, 2026

IBX says that on May 1, 2025 its Select Drug Program and Value formularies ended coverage of Zepbound for moderate to severe obstructive sleep apnea.Employer and commercial plans:On May 1, 2025, Independence Blue Cross (IBX) Select Drug Program® and Value Formularies ended coverage of Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA).provcomm.ibx.com, Sep 30, 2026
IBX says Zepbound OSA coverage ended immediately on May 1, 2025 for new prescriptions and on Aug. 1, 2025 or plan renewal (whichever first) for existing prescriptions.Employer and commercial plans:The change went into immediate effect on May 1, 2025, for new prescriptions. For patients (members) with an existing prescription, coverage ends on August 1, 2025, or when their insurance plan is renewed, whichever comes first.provcomm.ibx.com, Sep 30, 2026

IBX says Medicare allows coverage of Wegovy when prescribed for the cardiovascular indication.Medicare:Medicare will allow coverage for Wegovy® when prescribed for the cardiovascular indication.provcomm.ibx.com, Sep 30, 2026
IBX says it continues to cover GLP-1 drugs for FDA-approved conditions, including type 2 diabetes and cardiovascular disease, with prior authorization.Employer and commercial plans:IBX will continue to provide coverage for GLP-1 drugs prescribed to your patients (our members) for FDA-approved medical conditions and indications, including type 2 diabetes and cardiovascular disease, with prior authorization.provcomm.ibx.com, Sep 30, 2026

IBX says it continues to cover GLP-1 drugs for FDA-approved conditions including type 2 diabetes, with prior authorization.Employer and commercial plans:IBX will continue to provide coverage for GLP-1 drugs prescribed to your patients (our members) for FDA-approved medical conditions and indications, including type 2 diabetes and cardiovascular disease, with prior authorization.provcomm.ibx.com, Sep 30, 2026

IBX describes CMS’s Medicare GLP-1 Bridge as a temporary federal program running July 1, 2026 to Dec. 31, 2027 for eligible Part D beneficiaries, for weight management only.Medicare:Medicare GLP-1 Bridge, a temporary federal program (only running from July 1, 2026, to December 31, 2027), providing eligible Medicare Part D beneficiaries access to certain GLP-1 drugs for weight management only.provcomm.ibx.com, Sep 30, 2026
IBX says the Bridge is not a plan-sponsored IBX benefit and is independent of IBX coverage.Medicare:This temporary program from the federal government is not a plan-sponsored benefit through Independence Blue Cross (IBX).provcomm.ibx.com, Sep 30, 2026
IBX says it will continue to cover GLP-1 drugs for its Medicare Advantage members when prescribed for FDA-approved medical conditions (its coverage is not changing with the Bridge).Medicare Advantage:IBX will continue to cover GLP-1 drugs for Medicare Advantage members when prescribed for FDA-approved medical conditions.provcomm.ibx.com, Sep 30, 2026
IBX tells providers to send Bridge requests to the CMS central system, not to IBX.Medicare:Providers should submit Medicare beneficiary requests for access to the Bridge program through the central system and not to IBX.provcomm.ibx.com, Sep 30, 2026

IBX says members can search for a drug to see whether it is covered, its tier, and whether prior authorization applies.All plans:You can search for a drug to find out if it's covered, its tier, and if prior authorization or other considerations may be applicable.ibx.com, Sep 30, 2026
IBX’s drug search requires logging in.All plans:Log in to search for a drug.ibx.com, Sep 30, 2026

No web page from Independence Blue Cross that we could read covers: prior authorization criteria.
More detail, such as exact BMI cutoffs, is in 5 PDF documents from Independence Blue Cross, which we have not opened.
1 of its pages blocked automated reading.